ImmunityBio Inc.

Last updated September 27, 2026

Organization details

Legal name
ImmunityBio Inc.
Former names
NantKwest, Inc. Conkwest, Inc. ZelleRx Corp
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
SAN Diego
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
IBRX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001326110
EIN
43-1979754

Board of directors

Chief executives

Richard Adcock · CEO & President
Dates unknown

Director election results

Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

5 of this board's directors also sit on 5 other boards. 4 are in the same sector.

Network of ImmunityBio Inc.'s board connections PDS Biotechnology Corporation PDS Biotechnology Corp... Blue Acquisition Corp. Blue Acquisition Corp. Celldex Therapeutics Inc. Celldex Therapeutics I... GT Biopharma Inc. GT Biopharma Inc. United Therapeutics Corporation United Therapeutics Co... Bruce Wendel Bruce Wendel Cheryl Cohen Cheryl Cohen Linda Maxwell Linda Maxwell Patrick Soon-Shiong Patrick Soon-Shiong Wesley Clark Wesley Clark ImmunityBio Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$9,505,281
16 sales by 3 insiders
Date Insider Transaction Shares Price Value
Oct 5, 2026 Barry J. Simon Director Open-market sale −25,000 $10.75 $268,760
Oct 2, 2026 Cheryl Cohen Director Option exercise +55,979 $2.98 $166,817
Oct 2, 2026 Cheryl Cohen Director Open-market sale −81,056 $10.50 $851,088
Jul 2, 2026 Cheryl Cohen Director Option exercise +55,979 $2.98 $166,817
Jul 2, 2026 Cheryl Cohen Director Open-market sale −131,210 $9.50 $1,246,495
Jul 1, 2026 Christobel Selecky Director Option exercise +35,064 $2.98 $104,491
Jul 1, 2026 Christobel Selecky Director Option exercise +124,414 $2.99 $371,998
Jul 1, 2026 Christobel Selecky Director Open-market sale −159,478 $9.02 $1,438,492
Jun 30, 2026 Christobel Selecky Director Option exercise +700 $2.98 $2,086
Jun 30, 2026 Christobel Selecky Director Option exercise +300 $2.99 $897
Jun 30, 2026 Christobel Selecky Director Open-market sale −1,000 $9.00 $9,000
Jun 29, 2026 Christobel Selecky Director Option exercise +32,173 $2.98 $95,876
Jun 29, 2026 Christobel Selecky Director Option exercise +33,549 $2.99 $100,312
Jun 29, 2026 Christobel Selecky Director Option exercise +30,000 $2.84 $85,200
Jun 29, 2026 Christobel Selecky Director Open-market sale −95,722 $9.01 $862,455

Organizations in the same sector, closest in location and size first.

Questions about ImmunityBio Inc.

Who is the CEO of ImmunityBio Inc.?

Richard Adcock is ImmunityBio Inc.'s CEO & President.

How many directors are on ImmunityBio Inc.'s board?

ImmunityBio Inc.'s board has 10 directors: Barry J. Simon, Bruce Wendel, Cheryl Cohen, Christobel Selecky, John Owen Brennan, Linda Maxwell, Michael D. Blaszyk, Patrick Soon-Shiong, Richard Adcock and Wesley Clark.

Are ImmunityBio Inc. insiders buying or selling shares?

Over the last 12 months, ImmunityBio Inc. insiders made no open-market purchases and sold $9.5 million of shares in 16 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="immunitybio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.